Thursday, July 9, 2026

pharma · severe uncontrolled asthma · mild to moderate asthma, Chronic Obstructive Pulmonary Disease (COPD) · GENB

Generate Biomedicines

Generate Biomedicines patent portfolio — 1 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Somerville, USA HQ
325 Employees
Public company Type
GENB · NYSE Ticker
Company details
Status
Public
HQ
Somerville, USA
Employees
325
Programs
8
Drugs
7
Patents
1
Intelligence · Patents

Generate Biomedicines patents

1 pharmaceutical patents indexed for Generate Biomedicines. 0 expire within 24 months.

Generate Biomedicines has 1 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 11993644

    Antigen binding molecules targeting SARS-CoV-2

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Generate Biomedicines have?

1 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Generate Biomedicines patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.